Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04036773
Other study ID # 19413
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 14, 2019
Est. completion date December 15, 2020

Study information

Verified date April 2022
Source Oregon Health and Science University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Participants in the intervention group of this study will receive weekly home deliveries of fruit & vegetables for 3 months. The primary objective of this study is to determine if increased access to fruits and vegetables leads to sustained dietary changes, measured through changes in the Healthy Eating Index (HEI). Secondary objectives are to determine whether increased fruit and vegetable access (increased HEI) ultimately leads to improved cardiovascular (CV) health indicators (e.g., body mass index, waist circumference, blood pressure, and levels of blood lipids and hemoglobin A1c).


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date December 15, 2020
Est. primary completion date December 15, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: - Age 19 years and older - Established patient at OHSU Center for Preventive Cardiology - Not requiring changes to medication regimen for the 6-month study duration - Must be eligible to register with produce delivery company (reside in Portland-metro area; have access to a computer with internet service; able to read English) Exclusion Criteria: - Triglycerides > 500 mg/dL - Heavy alcohol use (> 3 drinks/day) - Uncontrolled hypertension (BP > 140/90) - LDL-C > 160 mg/dL - Uncontrolled diabetes mellitus (HbA1c > 8%) - Failure to provide informed consent - Current pregnancy - Healthy Eating Index (HEI) score of = 80

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Fruit and vegetable deliveries
Weekly home deliveries of approximately 15 pounds of fresh fruits & vegetables

Locations

Country Name City State
United States Oregon Health & Science University Portland Oregon

Sponsors (1)

Lead Sponsor Collaborator
Oregon Health and Science University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intake of fruits and vegetables measured by changes in Healthy Eating Index (HEI) The HEI uses a scoring system to evaluate a set of foods. The scores range from 0 to 100. An ideal overall HEI score of 100 reflects that the set of foods aligns with key dietary recommendations from the Dietary Guidelines for Americans. 6 months
Secondary Changes in weight measured by body mass index weight and height will be combined to report BMI in kg/m^2 6 months
Secondary Changes in waist circumference Waist circumference will be measured in inches using a tape measure; desirable: < 40 inches (men), < 35 inches (women) 6 months
Secondary Changes in total cholesterol measured via blood draw, desirable < 200 mg/dL 6 months
Secondary Changes in HDL-cholesterol measured via blood draw, desirable > 40 mg/dL 6 months
Secondary Changes in LDL-cholesterol measured via blood draw, desirable < 100 mg/dL 6 months
Secondary Changes in triglycerides measured via blood draw, desirable < 150 mg/dL 6 months
Secondary Changes in blood pressure Measured by medical assistant in clinic, desirable < 120/80 mmHg 6 months
Secondary Changes in blood glucose measured via blood draw, desirable range is 60-99 mg/dL 6 months
See also
  Status Clinical Trial Phase
Completed NCT03793985 - Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337 Phase 1
Recruiting NCT03947866 - Ezetimibe-Rosuvastatin Evaluation Study
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Completed NCT04516291 - A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70) Phase 2
Completed NCT04701775 - Effect of Different Probiotic Strains in Hypercholesterolemic Patients N/A
Completed NCT03632668 - Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072 Phase 1
Completed NCT03534661 - L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release Phase 2/Phase 3
Completed NCT03422666 - Plasma Lipoprotein Response to Glucagon-like Peptide-2 Phase 2/Phase 3
Completed NCT00536796 - Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets N/A
Completed NCT03643705 - A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention N/A
Recruiting NCT04560296 - Community-based E-Health Program for Older Adults Living With Chronic Diseases N/A
Terminated NCT04073134 - The CHORAL Flow Study Phase 4
Recruiting NCT05103254 - Bempedoic Acid Pregnancy Surveillance Program
Not yet recruiting NCT05015348 - Effects of Omega-3 PUFA on Lipids, Inflammatory Factors and Body Composition in Patients With Hyperlipidemia N/A
Active, not recruiting NCT05082350 - Nutritional Intervention With Black Garlic N/A
Not yet recruiting NCT04398771 - To Evaluate Safety and Effectiveness of RovatitanTab.
Not yet recruiting NCT04064281 - The Healthy Cantonese Diet on Cardiometabolic Syndrome N/A
Recruiting NCT06257641 - Impact of the Mediterranean Diet on Patients With Psoriasis N/A
Completed NCT03690778 - The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers. Phase 1
Completed NCT04354987 - Compare the Pharmacokinetics and Safety of CKD-391 Phase 1